IGMS - IGM Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IGMS is currently covered by 11 analysts with an average price target of $3.79. This is a potential upside of $2.49 (191.54%) from yesterday's end of day stock price of $1.3.

IGM Biosciences's activity chart (see below) currently has 74 price targets and 80 ratings on display. The stock rating distribution of IGMS is 50% HOLD, 44.74% BUY and 5.26% SELL.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 43.73% with an average time for these price targets to be met of 66.31 days.

Highest price target for IGMS is $11, Lowest price target is $1, average price target is $5.1.

Most recent stock forecast was given by ASTHIKA GOONEWARDENE from TRUIST on 11-Jun-2025. First documented stock forecast 03-Feb-2020.

Currently out of the existing stock ratings of IGMS, 19 are a HOLD (50%), 17 are a BUY (44.74%), 2 are a SELL (5.26%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1

$-0.27 (-21.26%)

$2

2 months 1 days ago
(11-Jun-2025)

2/8 (25%)

$-0.27 (-21.26%)

23

Hold

$9

6 months 30 days ago
(13-Jan-2025)

3/6 (50%)

$-5.5 (-37.93%)

48

Hold

$3

$1.73 (136.22%)

$22

7 months 2 days ago
(10-Jan-2025)

1/8 (12.5%)

$0.91 (43.54%)

90

Hold

$2.5

$1.23 (96.85%)

$27

7 months 2 days ago
(10-Jan-2025)

3/8 (37.5%)

$0.41 (19.62%)

73

Hold

$1.5

$0.23 (18.11%)

$20

7 months 2 days ago
(10-Jan-2025)

9/16 (56.25%)

$-0.59 (-28.23%)

78

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IGMS (IGM Biosciences) average time for price targets to be met?

On average it took 66.31 days on average for the stock forecasts to be realized with a an average price target met ratio 43.73

Which analyst has the current highest performing score on IGMS (IGM Biosciences) with a proven track record?

STEPHEN WILLEY

Which analyst has the most public recommendations on IGMS (IGM Biosciences)?

Stephen Willey works at STIFEL and has 12 price targets and 8 ratings on IGMS

Which analyst is the currently most bullish on IGMS (IGM Biosciences)?

Chris Howerton with highest potential upside - $33.85

Which analyst is the currently most reserved on IGMS (IGM Biosciences)?

Asthika Goonewardene with lowest potential downside - -$0.27

IGM Biosciences in the News

IGM Biosciences earnings beat by $1.70, revenue topped estimates

Investing.com – IGM Biosciences (NASDAQ: IGMS) reported second quarter EPS of $1.58, $1.70 better than the analyst estimate of $-0.12. Revenue for the quarter came in at $143.62M versus the consensus estimate of $400K. IGM Biosciences’s stock price closed at $1.28. It is up 13.27% in the last 3 months and down -85.87% in the...

IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates

IGM Biosciences, Inc. (IGMS) came out with quarterly earnings of $1.58 per share, beating the Zacks Consensus Estimate of a loss of $0.3 per share. This compares to a loss of $0.79 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +626.67%. A quarter...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?